US 9371529
RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
granted A61KA61K31/7105A61K31/713
Quick answer
US patent 9371529 (RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions) held by Arrowhead Research Corporation expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Research Corporation
- Grant date
- Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/7105, A61K31/713, A61P, A61P11/02